| Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain D De Gregorio*, RJ McLaughlin*, L Posa, R Ochoa-Sanchez, J Enns, ... Pain 160 (1), 136, 2019 | 348 | 2019 |
| d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology D De Gregorio, S Comai, L Posa, G Gobbi International journal of molecular sciences 17 (11), 1953, 2016 | 129 | 2016 |
| The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors D De Gregorio, L Posa, R Ochoa-Sanchez, R McLaughlin, S Maione, ... Pharmacological research 113, 81-91, 2016 | 92 | 2016 |
| d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: mechanism of action and potential therapeutic applications in mood disorders D De Gregorio, JP Enns, NA Nuñez, L Posa, G Gobbi Progress in brain research 242, 69-96, 2018 | 90 | 2018 |
| Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission D De Gregorio, J Popic, JP Enns, A Inserra, A Skalecka, A Markopoulos, ... Proceedings of the National Academy of Sciences 118 (5), e2020705118, 2021 | 70 | 2021 |
| Targeting melatonin MT2 receptors: a novel pharmacological avenue for inflammatory and neuropathic pain L Posa, D De Gregorio, G Gobbi, S Comai Current medicinal chemistry 25 (32), 3866-3882, 2018 | 65 | 2018 |
| Methadone reverses analgesic tolerance induced by morphine pretreatment L Posa*, A Accarie*, F Noble, N Marie International Journal of Neuropsychopharmacology 19 (7), pyv108, 2016 | 25 | 2016 |
| Dysfunction of serotonergic activity and emotional responses across the light‐dark cycle in mice lacking melatonin MT2 receptors S Comai, D De Gregorio*, L Posa*, R Ochoa‐Sanchez, A Bedini, G Gobbi Journal of Pineal Research 69 (1), e12653, 2020 | 24 | 2020 |
| Melatonin MT1 and MT2 receptors exhibit distinct effects in the modulation of body temperature across the light/dark cycle M López-Canul*, SH Min*, L Posa, D De Gregorio, A Bedini, G Spadoni, ... International Journal of Molecular Sciences 20 (10), 2452, 2019 | 24 | 2019 |
| Effects of chronic exposure to low-dose delta-9-tetrahydrocannabinol in adolescence and adulthood on serotonin/norepinephrine neurotransmission and emotional behavior D De Gregorio, J Dean Conway, ML Canul, L Posa, FR Bambico, G Gobbi International Journal of Neuropsychopharmacology 23 (11), 751-761, 2020 | 23 | 2020 |
| Nociceptive responses in melatonin MT2 receptor knockout mice compared to MT1 and double MT1/MT2 receptor knockout mice L Posa*, M Lopez‐Canul*, L Rullo, D De Gregorio, S Dominguez‐Lopez, ... Journal of Pineal Research 69 (3), e12671, 2020 | 16 | 2020 |
| Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward MC Gamble*, BR Williams*, N Singh*, L Posa, Z Freyberg, RW Logan, ... Frontiers in Systems Neuroscience 16, 2022 | 12 | 2022 |
| The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms FF Caputi, LDC Mannelli, L Rullo, L Micheli, S Stamatakos, L Posa, ... Biochemical Pharmacology 182, 114255, 2020 | 10 | 2020 |
| Supraspinal melatonin MT2 receptor agonism alleviates pain via a neural circuit that recruits mu opioid receptors L Posa, D De Gregorio, M Lopez‐Canul, Q He, E Darcq, L Rullo, ... Journal of Pineal Research 73 (4), e12825, 2022 | 6 | 2022 |
| & Gobbi, G.(2019). Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain D De Gregorio, RJ McLaughlin, L Posa, R Ochoa-Sanchez, J Enns, ... Pain 160 (1), 136, 0 | 6 | |
| Effects of different opioid drugs on oxidative status and proteasome activity in SH-SY5Y cells L Rullo, FF Caputi, LM Losapio, C Morosini, L Posa, D Canistro, ... Molecules 27 (23), 8321, 2022 | 4 | 2022 |
| Nociceptive behavior and central neuropeptidergic dysregulations in male and female mice of a Fabry disease animal model L Rullo*, L Posa*, FF Caputi, S Stamatakos, F Formaggio, M Caprini, ... Brain Research Bulletin 175, 158-167, 2021 | 3 | 2021 |
| Neuropsychopharmacological properties of novel melatonin MT1 receptor ligands S Comai, L Posa, R Ochoa-Sanchez, G Spadoni, G Gobbi European Neuropsychopharmacology 27, S569, 2017 | 3 | 2017 |
| Noradrenergic input from nucleus of the solitary tract regulates parabrachial activity in mice Y Ji, C Onwukwe, J Smith, H Laub, L Posa, A Keller, R Masri, N Cramer eneuro 10 (5), 2023 | 2 | 2023 |
| Noradrenergic input from nucleus of the solitary tract regulates parabrachial activity in mice C Onwukwe, Y Ji, J Smith, H Laub, L Posa, A Keller, R Masri, N Cramer bioRxiv, 2022.09. 29.510103, 2022 | 1 | 2022 |
Gabriella GobbiProfessor, McGill University, Montreal, CanadaDirección de correo verificada de mcgill.ca
